Incidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease

Uwajachukwumma A Uzomah1, Guy Rozen1, Seyed Mohammadreza Hosseini1

  • 1Cardiac Arrhythmia Service, MGH Heart Center, Massachusetts General Hospital, Boston, MA, United States of America.

Plos One
|November 3, 2021
PubMed

Insights

Approximately 11% of Lyme disease hospitalizations involve carditis, often affecting cardiac conduction. This study found 1% of all Lyme hospitalizations and 11% with conduction issues required permanent pacemakers, with older age and heart block as key predictors.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Lyme carditis, a direct cardiac infection by Borrelia bacteria, affects up to 10% of Lyme disease patients.
  • Cardiac conduction system disease is the most common manifestation of Lyme carditis.
  • Understanding pacemaker implantation incidence and predictors in Lyme carditis is crucial.

Purpose of the Study:

  • To determine the incidence of permanent pacemaker implantation in patients hospitalized with Lyme disease.
  • To identify predictors associated with permanent pacemaker implantation in this population.

Main Methods:

  • Retrospective cohort analysis of the Nationwide Inpatient Sample (2003-2014).
  • Defined Lyme carditis as hospitalization with Lyme disease and cardiac conduction disease, myocarditis, or pericarditis.
  • Excluded patients with pre-existing pacemaker implants; primary outcome was permanent pacemaker implantation.

Main Results:

  • 11% of 96,140 hospitalized Lyme disease patients had Lyme carditis.
  • Permanent pacemaker implantation occurred in 1% of all Lyme hospitalizations and 11% of those with Lyme carditis-associated conduction system disease.
  • Predictors for pacemaker implantation included older age, complete heart block, and sinoatrial node dysfunction.

Conclusions:

  • Lyme carditis affects approximately 11% of hospitalized Lyme disease patients, predominantly causing cardiac conduction issues.
  • Permanent pacemaker implantation was necessary for 1% of all hospitalized Lyme patients and 11% with Lyme-associated conduction disease.
  • Older age and specific conduction abnormalities predict the need for pacemakers in Lyme carditis.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
42
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
58
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
60
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
44
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
41